• Accueil >
  • Publications >
  • Two-year survival with nivolumab in previously treated advanced non–small-cell lung cancer: A real-world pooled analysis of patients from France, Germany, and Canada

Two-year survival with nivolumab in previously treated advanced non–small-cell lung cancer: A real-world pooled analysis of patients from France, Germany, and Canada

1 juil. 2021Lung Cancer

DOI : 10.1016/j.lungcan.2021.04.022

Auteurs

Didier Debieuvre, Rosalyn A. Juergens, Bernard Asselain, Clarisse Audigier-Valette, Jean-Bernard Auliac, Fabrice Barlesi, Nicolas Benoit, Pierre Bombaron, Charles A. Butts, Adrien Dixmier, Andreas Gröschel, Sylvia Gutz, Catherine Labbé, Denis Moro-Sibilot, Maurice Pérol, Christophe Raspaud, Christian Schumann, Ariadna Juarez-Garcia, Khalid Lakhdari, Filippa Pettersson, John R. Penrod, Dorothee Reynaud, Daniela Waldenberger, Victoria Allan, Martin Sebastian